Cantuzumab is a monoclonal antibody targeting the CanAg antigen with anti-tumor activity, used in the synthesis of the ADC compound cantuzumab mertansine.
Purity:
99.76%
CAS Number:
[1204740-23-7]
Target:
ADC Antibody
* VAT and and shipping costs not included. Errors and price changes excepted